The current study investigated the impact of PLK1 overexpression on disease prognosis in HR-positive early breast cancer (EBC) patients to demonstrate the PLK1 clinical relevance in HR-positive breast cancer. This evidence concerns the gene PLK1 and breast carcinoma.